News
Gastric cancer (GC), once primarily seen in older adults, is on the rise among younger individuals in developed countries. In ...
A young university student whose repeated symptoms of stomachache, nausea, vomiting, and weight loss were dismissed by ...
Endoscopies could be replaced by far less invasive capsule sponge tests for half of all patients with Barrett's esophagus, a ...
Researchers at the University of Texas at Dallas, led by bioengineering associate professor Dr. Girgis Obaid, are partnering ...
In a remarkable twist of science, researchers have transformed a fungus long associated with death into a potential weapon ...
Baldwin's widow called him "the most incredible man I ever met" when he died June 16, just months after his colon cancer ...
Stomach Cancer Care Team Stomach Cancer. At Fred Hutchinson Cancer Center, we surround you with experts who focus completely on cancer, day in and ... Sees you on a regular schedule to check how your ...
A new study shows that rates of appendix cancer are rising quickly among millennials and Generation X, especially compared to ...
Although cancer of the appendix is rare — typically, it's estimated to affect about 1 or 2 people for every 1 million in the ...
New treatment approaches are expanding the ways gastric cancer can be managed, with a focus on quality of life. Photos: Shutterstock, Icon Cancer Centre New: You can now listen to articles.
FDA limits Merck's Keytruda, Bristol Myers' Opdivo in stomach cancer By Angus Liu Jun 9, 2025 10:50am Merck & Co. Keytruda Bristol Myers Squibb Opdivo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results